AZIYO BIOLOGICS INC's ticker is AZYO and the CUSIP is 05479K106. A total of 16 filers reported holding AZIYO BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,366,913 | -39.4% | 1,655,184 | 0.0% | 2.01% | -31.2% |
| Q2 2023 | $3,906,234 | +156211.9% | 1,655,184 | 0.0% | 2.93% | +49.6% |
| Q1 2023 | $2,499 | -61.2% | 1,655,184 | +9.2% | 1.96% | -57.0% |
| Q4 2022 | $6,440 | -99.9% | 1,515,184 | +6.8% | 4.55% | -36.7% |
| Q3 2022 | $10,210,000 | +1.8% | 1,418,123 | 0.0% | 7.19% | -1.4% |
| Q2 2022 | $10,026,000 | +21.2% | 1,418,123 | +0.0% | 7.29% | +22.4% |
| Q1 2022 | $8,275,000 | -0.9% | 1,417,923 | 0.0% | 5.96% | +10.6% |
| Q4 2021 | $8,352,000 | +2300.0% | 1,417,923 | +2735.8% | 5.39% | +2172.6% |
| Q3 2021 | $348,000 | +20.8% | 50,000 | +66.7% | 0.24% | +37.8% |
| Q2 2021 | $288,000 | – | 30,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 1,655,184 | $2,499 | 1.96% |
| PERKINS CAPITAL MANAGEMENT INC | 275,329 | $416 | 0.39% |
| Prosight Management, LP | 196,443 | $296,629 | 0.14% |
| Indie Asset Partners, LLC | 26,500 | $40,015 | 0.05% |
| Knollwood Investment Advisory, LLC | 58,962 | $89,033 | 0.02% |
| Alyeska Investment Group, L.P. | 214,343 | $323,658 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,134 | $8 | 0.00% |
| US BANCORP \DE\ | 625 | $944 | 0.00% |
| WELLS FARGO & COMPANY/MN | 56 | $85 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |